Icon, Varian Partner to Expand Cancer Tech Access in the UK
Icon Group, a global leader in integrated cancer care, has announced a significant new agreement with Varian, a Siemens Healthineers company, involving an investment of...
Category : Healthcare and Pharmaceutical
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day
BRUKINSA, sonrotoclax, and BTK CDAC data, including combinations, are designed to comprehensively address unmet needs across CLL patient populations Promising new data from pipeline assets...
BioMarin Presents 5-Year Phase 3 Data on ROCTAVIAN® at ISTH 2025
Data from longest and largest hemophilia gene therapy study demonstrates sustained factor VIII expression and bleed control, with 81.3% of individuals remaining off prophylaxis No...
Nitinotes Gets FDA IDE Approval to Start U.S. Trial of EndoZip™ System
Advancing Minimally Invasive Obesity Treatment with Automated Suturing Technology Nitinotes, developer of the EndoZip™ System, a fully automated suturing platform for endoscopic sleeve gastroplasty (ESG),...
Innovent Presents Phase 3 DREAMS-1 Study of Mazdutide at ADA 85th
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and...
Breakthrough T1D Joins ADA 85th Sessions to Highlight Research Advances
Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, gathered with researchers, diabetes professionals, and other leaders in T1D...
Healthcare and LGBTQ+ Rights: How Pride Month Brings Awareness to Health Disparities
Explore how Pride Month sheds light on healthcare disparities faced by LGBTQ+ communities and advocates for inclusive, equitable medical care and rights. Every June, Pride...
Hemab Therapeutics Shares Positive Data on Bleeding Disorder Pipeline
Sutacimig Phase 2 interim results demonstrate >50% reduction in treated bleeding event and prophylactic treatment potential in Glanzmann thrombasthenia HMB-002 clinical proof-of-mechanism data in Von Willebrand...
Xcell Biosciences Partners with Thermo Fisher to Advance Cell Therapies
Strategic collaboration to innovate Treg and TIL therapies, streamline cell therapy workflows, and enhance manufacturing efficiency Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused...
Salesforce Collaborates With UChicago Medicine to Enhance Patient Support
The academic health system will soon handle personalized requests — like prescription refills and appointment scheduling — autonomously with Agentforce for Health to boost efficiency...
ForSight Robotics Raises $125M Series B to Tackle Surgeon Shortage
The funding round primes the company for tackling one of the most significant crises in global healthcare and for performing robotic cataract surgery clinical trials...
Study Validates Geneoscopy’s ColoSense® Real-World Impact
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the publication of a new study...
Sangamo Reports Positive Topline Results from STAAR Study
STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and...
IASO Bio Reports Positive MS Data for Equecabtagene at EAN Congress
IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that results...
Harbour BioMed, Otsuka Partner on BCMAxCD3 T-Cell Engagers
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a...